Ensign Peak Advisors
ELAN icon

Ensign Peak Advisors’s Elanco Animal Health ELAN Stock Holding History

Ensign Peak Advisors’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Buy
95,081
+63,571
+202% +$1.47M ﹤0.01% 710
2026
Q1 		$754K Hold
31,510
– – ﹤0.01% 881
2025
Q4 		$713K Sell
31,510
-57,200
-64% -$1.24M ﹤0.01% 876
2025
Q3 		$1.79M Sell
88,710
-53,650
-38% -$899K ﹤0.01% 832
2025
Q2 		$2.03M Sell
142,360
-18,000
-11% -$210K ﹤0.01% 905
2025
Q1 		$1.68M Sell
160,360
-866,160
-84% -$9.8M ﹤0.01% 979
2024
Q4 		$12.4M Sell
1,026,520
-150,917
-13% -$1.97M 0.02% 411
2024
Q3 		$17.3M Buy
1,177,437
+135,423
+13% +$1.89M 0.03% 353
2024
Q2 		$15M Hold
1,042,014
– – 0.03% 362
2024
Q1 		$17M Sell
1,042,014
-7,040
-0.7% -$110K 0.03% 351
2023
Q4 		$15.6M Sell
1,049,054
-1,555,940
-60% -$17.6M 0.03% 336
2023
Q3 		$29.3M Buy
2,604,994
+347,642
+15% +$4.04M 0.06% 227
2023
Q2 		$22.7M Buy
2,257,352
+185,257
+9% +$1.72M 0.05% 276
2023
Q1 		$19.5M Buy
2,072,095
+1,929,895
+1,357% +$22.8M 0.04% 285
2022
Q4 		$1.74M Buy
142,200
+34,400
+32% +$429K ﹤0.01% 864
2022
Q3 		$1.34M Buy
107,800
+1,800
+2% +$31.5K ﹤0.01% 937
2022
Q2 		$2.08M Buy
106,000
+1,200
+1% +$28.4K ﹤0.01% 787
2022
Q1 		$2.73M Sell
104,800
-21,895
-17% -$583K 0.01% 765
2021
Q4 		$3.6M Sell
126,695
-24,986
-16% -$777K 0.01% 765
2021
Q3 		$4.84M Sell
151,681
-244,929
-62% -$8.22M 0.01% 672
2021
Q2 		$13.8M Buy
+396,610
New +$13.1M 0.03% 372
2020
Q4 		– Sell
-24,550
Closed -$686K – 1865
2020
Q3 		$686K Sell
24,550
-31,763
-56% -$805K ﹤0.01% 1444
2020
Q2 		$1.21M Buy
+56,313
New +$1.24M ﹤0.01% 1214
2020
Q1 		– Sell
-155,175
Closed -$4.57M – 1642
2019
Q4 		$4.57M Buy
+155,175
New +$4.22M 0.01% 676

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Ensign Peak Advisors's ELAN Position: Q2 2026 in Review

Ensign Peak Advisors increased its Elanco Animal Health (ELAN) stake by 202% in Q2 2026, buying an estimated $1.47M and bringing the position to 95,081 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #710.

Ensign Peak Advisors first reported a position in ELAN in Q4 2019 and has held it in 24 quarters since. The position peaked at $29.3M in Q3 2023. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Ensign Peak Advisors held 95,081 shares of Elanco Animal Health worth $2.34M as of Q2 2026.
  • Ensign Peak Advisors bought 63,571 Elanco Animal Health shares in Q2 2026, an estimated $1.47M.
  • Elanco Animal Health made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #710 holding.
  • Ensign Peak Advisors first reported a position in Elanco Animal Health in Q4 2019 and has held it in 24 quarters since.
  • Ensign Peak Advisors's Elanco Animal Health position peaked at $29.3M in Q3 2023.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.